USFDA inspects Divis Laboratories’ Unit-II at Andhra Pradesh

07 Jun 2014 Evaluate

Divis Laboratories has undergone an inspection by the USFDA, with no major observations, for its Unit-II at Chippada village, Bheemunipatnam Mandal, near Visakhapatnam in state of Andhra Pradesh during June, 2014. The audit concluded with one observation primarily about further improvement of existing procedure. The purpose of this inspection was for Custom manufactured product.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

4586.75 -6.25 (-0.14%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.